Each Vial Contains 50mg GHK-CU + 10mg BPC-157 + 10mg TB-500 + 10mg KPV.

KLOW is a proprietary research blend combining four synergistic peptides, designed for advanced laboratory investigation into immune modulation, inflammation control, tissue repair, and cellular signaling.

Benefits (Research Focus)

• Multi-pathway research — studied for paired investigation across four distinct peptide signaling pathways in a single research blend

• Tissue repair pathways — investigated via BPC-157 and TB-500 components for angiogenesis and fibroblast migration endpoints

• Copper-peptide research — explored via GHK-Cu for fibroblast activation, collagen synthesis, and dermal matrix remodeling

• Anti-inflammatory signaling — examined via KPV (α-MSH–derived tripeptide) for NF-κB pathway and inflammatory cytokine modulation

• Comparative pharmacology — researched for paired vs single-compound endpoint differences across tissue repair, dermal, and inflammation models

Disclaimer

• This product is intended for laboratory research use only.
• Not for human or veterinary use.
• Not approved for diagnostic, therapeutic, or medical applications.
• Handle using appropriate laboratory safety procedures and personal protective equipment.